These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 25923368)
1. Synthesis and evaluation of 1,2,4-triazolo[1,5-a]pyrimidines as antibacterial agents against Enterococcus faecium. Wang H; Lee M; Peng Z; Blázquez B; Lastochkin E; Kumarasiri M; Bouley R; Chang M; Mobashery S J Med Chem; 2015 May; 58(10):4194-203. PubMed ID: 25923368 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in Vitro Antibacterial Evaluation of Novel 4-Substituted 1-Menthyl-1,2,3-triazoles. Khaligh P; Salehi P; Bararjanian M; Aliahmadi A; Khavasi HR; Nejad-Ebrahimi S Chem Pharm Bull (Tokyo); 2016; 64(11):1589-1596. PubMed ID: 27803470 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimicrobical evaluation of a novel class of 1,3,4-thiadiazole: derivatives bearing 1,2,4-triazolo[1,5-a]pyrimidine moiety. Luo Y; Zhang S; Liu ZJ; Chen W; Fu J; Zeng QF; Zhu HL Eur J Med Chem; 2013 Jun; 64():54-61. PubMed ID: 23644188 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents. Part II. Khera MK; Cliffe IA; Prakash O Bioorg Med Chem Lett; 2011 Sep; 21(18):5266-9. PubMed ID: 21835618 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives. Zhang SJ; Yang Q; Xu L; Chang J; Sun X Bioorg Med Chem Lett; 2012 Aug; 22(15):4942-5. PubMed ID: 22765891 [TBL] [Abstract][Full Text] [Related]
7. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE). Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of solithromycin analogs against multidrug resistant pathogens. Daher SS; Jin X; Patel J; Freundlich JS; Buttaro B; Andrade RB Bioorg Med Chem Lett; 2019 Jun; 29(11):1386-1389. PubMed ID: 30962084 [TBL] [Abstract][Full Text] [Related]
9. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine]. Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel quinazolin-4(3H)-one derivatives containing the 7-oxo-1,2,4-triazolo[1,5-a]pyrimidine moiety as effective agricultural bactericides against the pathogen Xanthomonas oryzae pv. oryzae. Du H; Fan Z; Yang L; Bao X Mol Divers; 2018 Feb; 22(1):1-10. PubMed ID: 28879615 [TBL] [Abstract][Full Text] [Related]
11. Vancomycin-Dependent Response in Live Drug-Resistant Bacteria by Metabolic Labeling. Pidgeon SE; Pires MM Angew Chem Int Ed Engl; 2017 Jul; 56(30):8839-8843. PubMed ID: 28570012 [TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide Antibiotics. Sakoulas G; Kumaraswamy M; Nonejuie P; Werth BJ; Rybak MJ; Pogliano J; Rice LB; Nizet V Antimicrob Agents Chemother; 2015 Oct; 59(10):6132-9. PubMed ID: 26195528 [TBL] [Abstract][Full Text] [Related]
13. Organoiodine(III) mediated synthesis of 3,9-diaryl- and 3,9-difuryl-bis-1,2,4-triazolo[4,3-a][4,3-c]pyrimidines as antibacterial agents. Prakash O; Kumar R; Kumar R; Tyagi P; Kuhad RC Eur J Med Chem; 2007 Jun; 42(6):868-72. PubMed ID: 17222483 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia. Abamecha A; Wondafrash B; Abdissa A BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911 [TBL] [Abstract][Full Text] [Related]
15. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates. Socha AM; LaPlante KL; Rowley DC Bioorg Med Chem; 2006 Dec; 14(24):8446-54. PubMed ID: 16979896 [TBL] [Abstract][Full Text] [Related]
16. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates. Rathnayake IU; Hargreaves M; Huygens F Syst Appl Microbiol; 2012 Jul; 35(5):326-33. PubMed ID: 22742879 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci. Singh K; Kumar S; Shekhar S; Dhawan B; Dey S J Med Chem; 2014 Nov; 57(21):8880-5. PubMed ID: 25291061 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis. Nicolaou KC; Hughes R; Cho SY; Winssinger N; Labischinski H; Endermann R Chemistry; 2001 Sep; 7(17):3824-43. PubMed ID: 11575783 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolated from artisanal food of animal origin in Argentina. Delpech G; Pourcel G; Schell C; De Luca M; Basualdo J; Bernstein J; Grenovero S; Sparo M Foodborne Pathog Dis; 2012 Oct; 9(10):939-44. PubMed ID: 22953740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]